[Federal Register: December 1, 1998 (Volume 63, Number 230)]
[Notices]               
[Page 66199]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de98-128]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 27, 1998, Celgene 
Corporation, 7 Powder Horn Drive, Warren, New Jersey 07059, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
2, 5-Dimethoxyamphetamine (7396)...........  I
4-Methoxyamphetamine (7411)................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
------------------------------------------------------------------------

    The firms plans to manufacture amphetamine for distribution of the 
bulk active substances to its customers, 4-methoxyamphetamine as an 
intermediate in the manufacturer of a non-controlled substance, 
methylphenidate for product research and development and 2,5-
dimethoxyamphetamine to develop, manufacture and sell compounds to 
pharmaceutical and agrochemical industries.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Adminstrator, Office of Diversion Control, Drug 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Department of Justice, Washington, DC 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than February 1, 1999.

    Dated: November 18, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-31969 Filed 11-30-98; 8:45 am]
BILLING CODE 4410-09-M